NCT00254995View on ClinicalTrials.gov

Descriptive, Post-marketing, Surveillance Safety Study of Menactra Vaccine

CompletedOBSERVATIONAL
Enrollment

62,626

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
MeningitisMeningococcal Disease
Interventions
BIOLOGICAL

None administered in this study

N/A in this study

Trial Locations (1)

94612

Oakland

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT00254995 - Descriptive, Post-marketing, Surveillance Safety Study of Menactra Vaccine | Biotech Hunter | Biotech Hunter